Bone Marrow Transplant Not the HIV Cure Many Hoped

Two men with HIV who underwent bone marrow transplants for the treatment of Hodgkin's lymphoma and then appeared to be free of HIV are again showing signs of the virus.

Disappointment was felt all around following the revelation that the two men, whose identities have not been made public, were found to be carrying the virus again.

Virus temporarily undetectable

One man underwent a transplant in 2008 and the other had his in 2010.

Approximately eight months after receiving the transplant, the HIV virus was undetectable in both men. Nonetheless, their doctors kept them on antiretroviral therapy until earlier this year, when both men came off the daily medication.

Unfortunately, one patient showed signs of the virus 12 weeks later and the other showed signs 32 weeks later. Fortunately both men are said to be doing well.

A case of genetic resistance

Thus far only one individual appears to have been cured of the virus: American Timothy Brown, who was HIV-positive and then diagnosed with leukemia. He underwent a bone marrow transplant and has shown no signs of the virus in the six years since.

The difference between the men appears to be the donor cells. In Timothy Brown, the donor cells had a genetic resistance to HIV because they lacked the CCR5 receptor, and it appears to have conferred this status to Brown. The donors for the other two men carried the receptor, known as a gateway for the virus to get inside the cells.

Despite the disappointment, scientists remain upbeat, claiming to have learned a substantial amount of information about the virus from these patients.

Source: AP

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap